Long Non-Coding RNA NANCI/NKX2-1 Duplex Impacts Prognosis in Stage I Non-Small-Cell Lung Cancer.

CONCLUSIONS: NANCI and the NANCI-NKX2-1 duplex impacts prognosis in stage I NSCLC patients. PMID: 32178834 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32178834?dopt=Abstract

Source: Archivos de Bronconeumologia - March 12, 2020 Category: Respiratory Medicine Authors: Moisés J, Navarro A, Castellano JJ, Viñolas N, Molins L, Canals J, Han B, Martín J, Ramirez J, Frigola G, Marrades RM, Monzó M Tags: Arch Bronconeumol Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine